Healthpeak Properties, Inc. 10-Q Summary
Business Context and Reporting Period
Company: Healthpeak Properties, Inc. (NYSE: DOC)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: A healthcare-focused REIT owning outpatient medical, lab, and senior housing real estate. The period was defined by the March 2026 Initial Public Offering (IPO) of its senior housing subsidiary, Janus Living, Inc., and a subsequent June 2026 follow-on offering.
Key Financial Metrics
| Metric (Six Months Ended June 30, 2026) | 2026 | 2025 |
|---|---|---|
| Total Revenues | $1,524.5 million | $1,397.2 million |
| Net Income (Applicable to Common Shares) | $246.2 million | $73.9 million |
| Diluted EPS | $0.36 | $0.11 |
| Operating Cash Flow | $622.0 million | $642.9 million |
| Investing Cash Flow | ($506.0 million) | ($441.0 million) |
| Financing Cash Flow | $1,065.0 million | ($223.0 million) |
| Cash & Equivalents (End of Period) | $1,626.8 million | $467.5 million |
| Total Debt (Principal) | $10.0 billion | $9.8 billion |
| Weighted Avg Interest Rate (Fixed) | 4.17% | 4.15% |
Material Changes vs. Prior Period
- Net Income Surge: Net income applicable to common shares increased 233% year-over-year ($246.2M vs. $73.9M). This was driven primarily by a $138.3 million gain upon change of control (related to the SWF JV Buyout and BX JV transactions) and a $60.7 million gain on sales of real estate.
- Revenue Growth: Total revenues rose 9.1% to $1.52 billion, fueled by a 40% increase in resident fees and services due to the consolidation of the SWF Senior Housing JV and new senior housing acquisitions.
- Liquidity Expansion: Cash and cash equivalents increased by $1.16 billion to $1.63 billion, largely due to $1.59 billion in net proceeds from the Janus Living IPO and follow-on offering.
- Debt Profile: Total debt increased slightly to $10.0 billion. The company repaid $245 million in mortgage debt and $650 million in senior unsecured notes (July 2026 maturity) while increasing commercial paper borrowings.
- Segment Performance:
- Senior Housing: Adjusted NOI increased 16.4% (Same-Store) and 19.2% (Total Portfolio) due to higher occupancy and resident fee rates.
- Lab: Adjusted NOI decreased 5.0% (Same-Store) due to lower occupancy and higher operating expenses.
- Outpatient Medical: Adjusted NOI remained relatively flat (Same-Store up 2.5%) driven by rent escalations offset by higher operating costs.
Guidance, Outlook, and Risks
- Capital Allocation: The company utilized Janus Living proceeds to fund acquisitions and debt repayments. A new $500 million share repurchase program was approved in July 2026 to replace the expired 2024 program.
- Dividends: Monthly common stock cash dividends of $0.10167 per share were declared for July, August, and September 2026.
- Key Risks:
- Interest Rate Sensitivity: A 1% increase in interest rates would increase annual interest expense by approximately $16 million on variable rate debt.
- Market Conditions: Elevated interest rates and inflation continue to impact construction costs and tenant liquidity, particularly in the lab sector.
- Janus Living Integration: Risks associated with the economic exposure to Janus Living stock price and the ability to control assets post-IPO.
Investor Verification Checklist
- Janus Living Ownership: Verify the 73.6% economic ownership stake Healthpeak retains in Janus Living and the associated noncontrolling interest dilution.
- Gain on Change of Control: Confirm the sustainability of the $138.3 million gain recognized from the SWF JV Buyout and BX JV transactions, as these are non-recurring items.
- Debt Maturities: Review the $650 million senior unsecured note repayment scheduled for July 2026 and the company's refinancing strategy.
- Lab Occupancy: Monitor the 87.5% occupancy rate in the Lab segment, which remains below historical levels and is a primary driver of NOI decline in that sector.
- Share Repurchase Capacity: Note the expiration of the 2024 repurchase program and the activation of the new $500 million 2026 program.